Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy

Acta Obstetricia et Gynecologica Scandinavica, Supplement

Volumn 76, Issue 164, 1997, Pages 94-97

  Stjernquist, Martin ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibroids; GnRH; GnRH analogues; Hysterectomy; Myoma

Indexed keywords

GONADORELIN DERIVATIVE; DRUG DERIVATIVE; GONADORELIN;

BLEEDING; BONE DISEASE; CONFERENCE PAPER; ENDOCRINE DISEASE; FEMALE; HUMAN; HYSTERECTOMY; LENGTH OF STAY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TUMOR VOLUME; UTERUS MYOMA; ARTICLE; DRUG POTENTIATION; LEIOMYOMA; MULTIMODALITY CANCER THERAPY; UTERUS CANCER;

COMBINED MODALITY THERAPY; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYSTERECTOMY; LEIOMYOMA; UTERINE NEOPLASMS;

EID: 0030763127     PISSN: 03008835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Schally AV. Aspects of hypothalamic regulation of the pituitary gland: its implications for the control of reproductive processes. Science 1978; 202: 18-28.
2. Belchetz PE, Plant TM, Nakai Y, Koegh EJ, Knobil E. Hypophysial response to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978; 202: 631-3.
3. 2+ levels. Mol Pharmacol 1984; 25: 51-5.